Antifungal medication is efficient in the treatment of sarcoidosis

Therapeutic Advances in Respiratory Disease

Volumn 5, Issue 3, 2011, Pages 157-162

  Terčelj, Marjeta ^a   Salobir, Barbara ^a   Zupancic, Mirjana ^a   Rylander, Ragnar ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Biofact Environmental Health Research Center   (Sweden)

Author keywords

antifungal; corticosteroids; fungi; sarcoidosis

Indexed keywords

ANTIFUNGAL AGENT; CHITOTRIOSIDASE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; ITRACONAZOLE; METHYLPREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; LUNG DIFFUSION; MALE; MYCOSIS; PRIORITY JOURNAL; SARCOIDOSIS; SCORING SYSTEM; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HEXOSAMINIDASES; HUMANS; ITRACONAZOLE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 79957806056     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465811401648     Document Type: Article

References (19)

1. ATS/ERS. (1999) Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 160: 736–755.
2. Bachelez H. Senet P. Cadranel J. Kaoukhov A. Dubertret L. (2001) The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 137: 69–73.
3. Conron M. Beynon H.L. (2000) Ketoconazole for the treatment of refractory hypercalcemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 3: 277–280.
4. Denning D.W. O–Driscoll B.R. Powell G. Chew F. Atherton G.T. Vyas A. (2009) Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization. Am J Resp Crit Care Med 179: 11–18.
5. Iannuzzi M.C. Rybicki B.A. Tierstein A.S. (2007) Sarcoidosis. New Engl J Med 357: 2153–2165.
6. Kasahara Y. Ashikara Y. (1981) Colorimetry of angiotensin-1 converting enzyme activity in serum. Clin Chem 27: 1922–1925.
7. Kern D.G. Neill M.A. Wrenn D.S. Varone J.C. (1993) Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 148: 974–980.
8. Keijsers R.G. Verzijbergen J.F. van Diepen D.M. van den Bosch J.M. Grutters J.C. (2008) 18F-FDG PET in sarcoidosis: An observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 25: 143–149.
9. Keir G. Wells A.U. (2010) Assessing pulmonary disease and response to therapy: Which test? Semin Respir Crit Care Med 31: 409–418.
10. Kucera G.P. Rybicki B.A. Kirkey K.L. Coon S.W. Major M.L. Maliarik M.J. (2003) Occupational risk factors for sarcoidosis in African-American siblings. Chest 123: 1527–1535.
11. Laney A.S. Cragin L.A. Blevins L.Z. Sumner A.D. Cox-Ganser J.M. Kreiss K. (2009) Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building. Indoor Air 19: 83–90.
12. Newman L.S. Rose C.S. Bresnitz E.A. the ACCESS research group (2004) A case-control etiological study of sarcoidosis ’ environmental and occupational risk factors. Am J Respir Crit Care Med 170: 1324–1330.
13. Prezant D.J. Dhala A. Goldstein A. Janus D. Ortiz F. Aldrich T.K. (1999) The incidence, prevalence, and severity of sarcoidosis in New York firefighters. Chest 116: 1183–1193.
14. Rylander R. (2010) Organic dust induced pulmonary disease ’ the role of mould derived β-glucan. Ann Agr Environ Med 17: 9–13.
15. Silzbach L.E. Teirstein A.S. (1964) Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand 425: 302S–308S.
16. Terčelj M. Rott T. Rylander R. (2007) Antifungal treatment in sarcoidosis ’ a pilot intervention trial. Respir Med 101: 774–778.
17. Terčelj M. Salobir B. Rylander R. (2008) Microbial antigen treatment in sarcoidosis ’ a new paradigm? Med Hypotheses 70: 831–834.
18. Terčelj M. Salobir B. Rylander R. (2011) Fungal exposure in homes of patients with sarcoidosis ’ an environmental exposure study. Environ Health 10: 8–8.
19. Terčelj M. Salobir B. Simčič S. Wraber B. Zupancic M. Rylander R. (2009) Chitotriosidase activity in sarcoidosis and some other pulmonary diseases. Scand J Clin Lab Invest 69: 575–578.